Organ-Specific Molecular Classification of Primary Lung, Colon, and Ovarian Adenocarcinomas Using Gene Expression Profiles
- 1 October 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (4), 1231-1238
- https://doi.org/10.1016/s0002-9440(10)62509-6
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA81488, CA84952, CA46952)
- University of Michigan Comprehensive Cancer Center (CA81488, CA84952, CA46952)
- National Cancer Institute (CA81488, CA84952, CA46952)
This publication has 17 references indexed in Scilit:
- Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the LungThe American Journal of Surgical Pathology, 2001
- Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerProceedings of the National Academy of Sciences, 2001
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- Molecular classification of cutaneous malignant melanoma by gene expression profilingNature, 2000
- Two Functionally Distinct Forms of NKX2.1 Protein Are Expressed in the Pulmonary EpitheliumBiochemical and Biophysical Research Communications, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?Pathology - Research and Practice, 2000
- Estrogen Receptor Alpha (ER-α) and Beta (ER-β) mRNAs in Normal Ovary, Ovarian Serous Cystadenocarcinoma and Ovarian Cancer Cell Lines: Down-Regulation of ER-β in Neoplastic TissuesJournal of Clinical Endocrinology & Metabolism, 1998
- Estrogen Receptor Alpha (ER- ) and Beta (ER- ) mRNAs in Normal Ovary, Ovarian Serous Cystadenocarcinoma and Ovarian Cancer Cell Lines: Down-Regulation of ER- in Neoplastic TissuesJournal of Clinical Endocrinology & Metabolism, 1998
- Vimentin: an evaluation of its role as a tumour markerHistopathology, 1987